trending Market Intelligence /marketintelligence/en/news-insights/trending/jtSwxh_ErKwhuNYKsEKeKw2 content esgSubNav
In This List

Trice Medical concludes $19.3M series C financing round

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Trice Medical concludes $19.3M series C financing round

Trice Medical Inc. closed a series C financing round, raising $19.3 million.

The company will use proceeds to accelerate and expand the company's U.S. market penetration for its mi-eye 2 technology.

The mi-eye 2 is a disposable needle with a wide-angle camera that allows physicians to diagnose joint injuries from the doctor's office.

Trice Medical has raised $40.9 million to date, including the series C financing round, which saw Smith & Nephew PLC take a minority stake in the company.